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Abstract
Background: Efficient generation of structured dose instructions that enable researchers
to calculate drug exposure is central to pharmacoepidemiology studies. Our aim was to
design and test an algorithm to codify dose instructions, applied to the NHS Scotland
Prescribing Information System (PIS) that records about 100 million prescriptions per
annum.
Methods: A natural language processing (NLP) algorithm was developed that enabled
free-text dose instructions to be represented by three attributes – quantity, frequency and
qualifier – specified by three, three and two variables, respectively. A sample of 15 593
distinct dose instructions was used to test, validate and refine the algorithm. The final
algorithm used a zero-assumption approach and was then applied to the full dataset.
Results: The initial algorithm generated structured output for 13 152 (84.34%) of
the 15 593 sample dose instructions, and reviewers identified 767 (5.83%) incorrect
translations, giving an accuracy of 94.17%. Following subsequent refinement of the
algorithm rules, application to the full dataset of 458 227 687 prescriptions (99.67% had
dose instructions represented by 4 964 083 distinct instructions) generated a structured
output for 92.3% of dose instruction texts. This varied by therapeutic area (from 86.7%
for the central nervous system to 96.8% for the cardiovascular system).
Conclusions: We created an NLP algorithm, operational at scale, to produce structured
output that gives data users maximum flexibility to formulate, test and apply their own
assumptions according to the medicines under investigation. Text mining approaches
can provide a solution to the safe and efficient management and provisioning of large
volumes of data generated through our health systems.
VC The Author(s) 2018. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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Introduction
As health systems become more digitized, the volume and
complexity of information grow rapidly and place demands
on data providers to adopt new approaches to manage and
provision these data in a form that promotes safe, effective
and efficient use by stakeholders. Medicines are the most
frequently used health technology, accounting for a rising
proportion of health care budgets, and their impact is of
interest to patients, clinicians, manufacturers and payers.1
The consequence is an ever-increasing demand to examine
how medicines are being used in routine clinical practice,
against a reducing evidence base as the medicines regulation
landscape responds to growing public pressure for acceler-
ated access through the concept of ‘adaptive licensing’.2
Drug utilization and pharmacoepidemiology studies
seek to address this by better understanding how we use
medicines in routine care and their effects, intended and
unintended.3–5 Critical to this endeavour is a requirement
for access to quality data on individual drug exposure
across populations.6 The challenge is that most electronic
prescribing systems permit prescribers to record dose in-
structions as free text, not structured data. The conse-
quence is an extensive use of researchers’ time deployed to
transform these data into a usable format by variable
methods, often poorly documented, to calculate drug ex-
posure.7 One solution is the application of rule-based nat-
ural language processing (NLP) methods to rapidly
generate valid structured variables from free text, enabling
drug exposure periods to be constructed consistently and
reproducibly. NLP methods offer the ability to extract
structured or standardized information from free texts in
large volumes by defining sets of rules and lexicons in an
iterative process.8
This approach is not new, with early applications often
seeking to identify the presence of medicine prescribing
attributes within clinical notes9–11 but not permitting calcula-
tion of drug exposure time periods. Shah et al.12 reported the
application of a simple algorithm to a research database to
codify free-text dose instructions to generate a derived daily
dose. Karystianis et al.7 highlighted that the adoption of the
Shah approach limited the ability of researchers to under-
stand potential important variability in dosage information
(e.g. two tablets up to three times daily would generate a sin-
gle average-value daily dose of three tablets). They designed
and tested a model to represent the variability and flexibility
in drug directions, including the concept of minimum and
maximum values for drug dosage, frequency and interval.7
Our study builds on this evidence and reports the design,
testing and routine adoption at scale of a zero-assumption
approach to the codification of free-text dosage information
applied to the National Health Service (NHS) Scotland
Prescribing Information System (PIS).13
Methods
Data source
The PIS is an administrative database recording all NHS
prescriptions prescribed, dispensed and reimbursed in the
community in Scotland.13 The PIS records information for
about 100 million prescriptions per annum, around 98%
of which include a unique person identifier. General practi-
tioner (GP) prescribing accounts for about 95% of records,
and these include an electronic prescription message
containing free-text dose instructions. Other health care
professionals’ prescriptions are largely paper-based, from
which dose instructions are not captured. As the NHS is
the universally used health care system in Scotland, the PIS
provides a comprehensive record of primary care prescrib-
ing for a population of 5.3 million.
Key Messages
• A natural language processing (NLP) algorithm was developed to enable free-text dose instructions from 458 227 687
prescriptions of the NHS Scotland Prescribing Information System (2009–15) to be represented as quantity, frequency
and qualifier.
• The final algorithm after clinical validation generated an overall structured output of 92.3%, which varied by thera-
peutic area (from 86.7% for the central nervous system to 96.8% for the cardiovascular system).
• Researchers can request a free-text dose instruction translated output as part of their PIS data extract for studies of
systemic therapies through the eDRIS service run by NHS National Services Scotland [www.isdscotland.org/Products-
and-Services/eDRIS/].
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The study dataset included all electronic prescription
messages for systemic therapies from April 2009 to May
2015 (inclusive). Each preparation prescribed is identifiable
by a unique code based on the therapeutic groupings of the
British National Formulary (BNF).14 These were used to
identify systemic therapies and exclude topical treatments,
which generally do not include information about the quan-
tity to be administered within the dose instructions. The
free-text dose instructions were initially cleansed to remove
potentially confidential or disclosive information. The dose
instruction free texts were then stratified according to the
frequency with which they occurred (i.e.  1000, 100–999,
10–99, 2–9 times or once only within the dataset).
Phase 1: Definition of attributes and algorithm development
In common with others,7,12 we recognized that free-text
dose instructions could be represented by three attributes–
quantity, frequency and qualifier–each of which is then speci-
fied by a set of variables. An initial review of the 1000 most
frequently occurring dose instructions identified that quan-
tity and frequency attributes could each be represented by
three variables to define minimum and maximum values and
unit or period of measure, whereas qualifier was represented
by two Boolean variables indicating ‘as directed’ or ‘as
required’ (Table 1). We applied NLP methods to extract
structured output defined by those variables using the Ciao
implementation of the Prolog general purpose programming
language [http://ciao-lang.org]. This was chosen because of
the ease with which it is possible to include grammar syntax
within the executable program.8 Words not associated with
quantity or frequency information were ignored using rules.
These rules checked for defined phrases and tested whether
there existed a variable-length phrase that failed to satisfy
any rule used to identify quantity or frequency information
(e.g. ‘dispense by instalment’, ‘dissolve sachet’).
The 1000 dose instructions were then processed using the
algorithm, and the structured outputs were inspected manu-
ally for completeness and correctness. The rules and lexicons
were modified and extended with the aim of achieving struc-
tured output for at least 85% of the distinct dose instruction
and an error rate <1%. The process was repeated for
sequential aliquots of the next 1000 most frequent instruc-
tions, until all with a frequency 1000 had been processed.
Finally, a random sample of 500 dose instructions from each
of the lower-frequency strata was introduced and the process
repeated. Retrospective checking was performed to ensure
that algorithm changes did not have a negative impact on the
output compared with previous versions.
Phase 2: Clinical validation and refinement
All free-text dose instructions with a frequency 1000,
and a new random sample of 500 from each of the other
strata, were processed by the algorithm. The dose instruc-
tions, their structured outputs and any untranslated
instructions were split into files. Each file was manually
assessed by at least two reviewers from the Farr
Institute@Scotland Pharmacoepidemiology Group, which
included pharmacists, medical clinicians and researchers.
Reviewers were asked to identify any errors and propose
expected structured output for untranslated instructions.
This feedback was used to refine the algorithm further,
with retrospective checking to ensure no impact on the
previously correct structured outputs.
Phase 3: Application of the final algorithm
The finalized algorithm was used to process the free-text
dose instructions for all prescriptions in the dataset by
therapeutic grouping. Output measures were the number
of prescriptions with a structured output produced plus the
number in which an element of discretion was exhibited
(i.e. a range in quantity or frequency, or the presence of a
qualifier, e.g. ‘one or two to be taken 4-6 hourly as
required’).
Results
For the period April 2009 to May 2015, there were
544 783 687 prescriptions with an electronic prescription
message record, of which 458 227 687 related to systemic
therapies. Of these, 456 684 974 (99.67%) had free-text
dose instructions within the message. These dose instruc-
tions were represented by 4 964 083 distinct free-text dose
instructions. A total of 13 593 (0.27%) distinct free-text
dose instructions occurred 1000 times, accounting for
405 743 493 (88.85%) of all prescriptions with a free-text
dose instruction. A further 75 081 (1.5%) distinct dose
instructions occurred between 100 and 999 times within
the dataset and accounted for an additional 20 293 362
(4.44%) prescription items (Table 2).
Phase 1
Initial inspection of the 1000 most frequently occurring
free-text dose instructions affirmed that these could be
represented by three attributes and associated variables.
We adopted a zero-assumption approach (i.e. we did not
assume a minimum quantity or frequency of zero in the
presence of an ‘as required’ qualification). The representa-
tion of dose frequency was, however, modified to differen-
tiate between doses within a period (e.g. twice daily)
and intervals between doses (e.g. every 6 hours) (Table 1).
A quantity unit is often omitted within free-text dose
instructions and, even when present, is often implicit in the
posological dose form (e.g. ‘one [tablet] to be taken at
night’). We therefore modified the rules and lexicon so that
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a quantity unit was only specified within the structured
output when it would impart additional meaning (e.g. ‘mg’
or ‘ml’). Table 3 presents a selection of dose instruction
texts and how these are represented within the structured
model.
Phase 2
A total of 15 593 free-text dose instructions that comprised
all 13 593 distinct instructions occurring  1000 times
plus 500 from each of the other strata (Table 2) were
reviewed. The algorithm produced structured output for
13 152 (84.34%) instructions, and reviewers identified 767
(5.83%) incorrect translations, giving an algorithm accu-
racy of 94.2%. Additionally, reviewers were able to pro-
vide interpretations for 48% of untranslated dose
instructions that were used to refine the algorithm further.
The most significant change was to differentiate between
dose frequency within a period and specification of an
interval between doses. Reviewers felt that a literal
interpretation of, for example, ‘every 4 hours’ to mean six
times per day, was likely to lead to overestimation of
consumption. Additionally, ‘unit tests’ that automate the
detection of errors introduced by algorithm changes were
implemented.
The final algorithm comprised 23 high-level grammar
rules to identify the three main dose attributes, with a
further 217 rules that identified the values to populate the
specific variable and information within dose instructions
that could be ignored. These were supported by lexicons
containing 1242 words and phrases, including spelling
variants (Table 4).
Phase 3
Table 5 presents, by therapeutic area, the output of the
final algorithm applied to all 458 227 687 prescriptions in
the dataset. Overall, the algorithm generated structured
output for 92.3% of prescriptions, but this ranged from
86.7% for central nervous system (CNS) drugs to 96.8%
for cardiovascular system (CVS) drugs. The proportion of
dose instructions that allowed a degree of discretion (i.e. a
range in quantity or frequency, or the presence of a quali-
fier) was <1% for most therapy areas, but was much
higher for those where drugs are often used to provide
symptomatic relief: musculoskeletal (4.9%); gastrointesti-
nal (5.2%); respiratory (6.7%); and CNS drugs (21.3%),
which encompass pain management.
Discussion
Interpreting and understanding medication dose instruc-
tions relies upon knowing how much and how often a
medicine is to be taken. These are elementary concepts, so
we adopted a pragmatic approach in which we aimed to
transform free-text dose instructions into regular struc-
tured information that could be readily used by research
teams. This study, one of only a small number of published
studies, reports our experience with the application of NLP
approaches at scale to the NHS Scotland national prescrib-
ing dataset. Our study dataset comprised 458 227 687
prescriptions, of which 99.67% had dose instructions
represented by 4 964 083 distinct texts; 13 593 (0.27%) of
these occurred 1000 times, accounting for 405 743 493
(88.85%) of all the prescriptions with a free-text dose
instruction. We developed an NLP algorithm which, on
application to the study dataset, generated an overall struc-
tured output of 92.3% (ranging from 86.7% for CNS
drugs to 96.8% for CVS drugs).
The application of NLP methods to support the inter-
pretation of unstructured dose instructions, still common-
place in electronic prescribing systems, has the potential to
significantly improve the efficiency of conducting drug
Table 1. Structured Dose Instruction Model
Dose attribute Description Variables
Quantity The amount to be taken in
each dose and the unit of
measure, e.g. 5–10 ml
Amount_min
Amount_max
Amount_unit
Frequency The number of times within a
period that a dose should be
taken and the period of
measurement, e.g. 2–3 times
a day
Freq_min
Freq_max
Freq_unit
The interval between doses,
e.g. 4–6 hourly
Interval_min
Interval_max
Interval_unit
Qualifier Boolean variables to indicate
further qualification of dose
or frequency
As_required
As_directed
Table 2. Number of prescriptions by dose instruction frequency
(2009–15) in the NHS Scotland Prescribing Information system
(PIS) dataset
Frequency of
dose instruction
free-text
No. of distinct
dose instructions
Total no. of
prescriptions
 1000 13 593 405 743 493
100 to 999 75 081 20 293 362
10 to 99 839 322 21 959 830
2 to 9 1 175 767 5 827 969
1 2 860 320 2 860 320
Total 4 964 083 456 684 974
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utilization and pharmacoepidemiology studies; free-text
dose instructions are cumbersome and can be difficult to
interpret and analyse in large volumes. Transformation
into structured dose attributes can enable calculations to
be more easily performed to derive the intended daily dose,
and to estimate the expected duration for which a prescrip-
tion will provide treatment. This is the foundation on
which further work can be performed to roll up prescribing
events for different medicinal products containing the
same active ingredient and combine records that overlap
in time, subject to a persistence window, to generate
measures to estimate adherence and drug eras to explore
clinical outcome and safety.15,16
Our data model shares similarities with the approach
used by Shah et al.12 and built upon by Karystianis et al.7
However, Shah et al. outputted a single numerical value
for the amount to be consumed daily, with a flag to indi-
cate whether this was a calculated average and if consump-
tion was ‘as needed’, whereas Karystianis et al. outputted
more granular information but converted the dose intervals
to the number of times per day and set the minimum
frequency to zero for ‘as required’ prescriptions. Both
methods allow identification of variability within a dose
instruction but lose elements of detail. In contrast, we have
separated dose frequency information according to
whether the instructions are based on a number of doses to
be taken within a period (e.g. twice per day) or with an
interval between each dose (e.g. every 4 hours), and
separately present the variables ‘as required’ and ‘as
directed’ as a qualifier attribute. This is consistent with our
intention of developing a zero-assumption approach to our
data provisioning.
The performance of our algorithm was validated
through manual inspection by a multidisciplinary group,
producing an accuracy of 94.2% (n ¼ 13 152). This com-
pares favourably to an accuracy of 98.8% (n ¼ 1000) from
Shah et al.12 and 90.9% (n ¼ 220) from Karystianis et al.7
Unsurprisingly, our free-text dose instruction data include
many of the issues previously identified by others, includ-
ing misspellings, the use of acronyms and abbreviations
and structural ambiguity.7 Some of these we have
addressed by extending the lexicons used by the NLP algo-
rithm, and others are resolved by the rule-set that looks for
sequences or proximity of words to deduce meaning.
However, our model remains challenged by complex dose
instructions such as those that call for one dose to be taken
for a period of time followed by a different dose (e.g. ‘one
daily for 5 days and then one twice daily thereafter’). Our
final algorithm is a balance between the drive towards
dedicated rules to characterize individual distinct free-text
dose instructions, and maintaining a manageable number
of generic rules.
Our study reports, for the first time, analysis of the level
of translation by individual therapeutic area, identified by
Shah et al. as a limitation.12 The results reflect the com-
plexity and flexibility in treatment regimens adopted in the
Table 3. Examples of dose instructions and their structured output
Quantity Frequency Qualifier
Period Interval
Dose instructions Min Max Unit Min Max Unit Min Max Unit As As
required directed
Take two tablets four
times daily
2 2 4 4 Day
A half to one tablet two
to three times a day
when required
0.5 1 2 3 Day TRUE
10 mg to be taken
weekly
10 10 mg 1 1 Week
Two with each meal 2 2 3 3 Day
Take 2.5 ml twice a day 2.5 2.5 ml 2 2 Day TRUE
Half a tablet twice a day
when required
0.5 0.5 2 2 Day TRUE
Two puffs 6-hrly prn 2 2 Puff 6 6 hour TRUE
One to three every day 1 3 1 1 Day
One or two to be taken
every 4 to 6 hours
1 2 4 6 hour
One twice daily as
directed
1 1 2 2 Day TRUE
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management of acute and chronic disease. For example,
cardiovascular disease had the highest translation rate
(96.8%) and one of the lower rates for dosage flexibility
(0.3%), affirming a level of dosage standardization in
treatment. In contrast, CNS drugs, which include pain
management therapy, illustrated the lowest translation rate
(86.7%) and the highest dosage flexibility (21.3%), a con-
sequence of individual dosage titration often over time in
this therapeutic area. Furthermore, although the extent of
use of qualifiers was relatively low, this also varied by ther-
apeutic area. These data provide useful and important
intelligence for researchers choosing to use real-world
administrative datasets in their studies.
Limitations
This study has a number of limitations. First, the model is
dependent on the prescriber recording a dose instruction
(99.67% in our sample) and including dose and frequency
attributes (92.3%), to enable the algorithm to generate a
structured output. Nevertheless, the present level of trans-
lation supports researchers to readily derive daily dose
exposure for the majority of prescriptions, relying on man-
ual interpretation and/or development of specific rules for
any untranslated instructions. Second, we have built the
NLP algorithm based on only systemic therapies covering
BNF chapters 1–10. This largely omits topical and other
non-oral therapies that account for 15% of prescriptions
within the PIS dataset. However, it is likely that the algo-
rithm would produce some structured output for these; but
elements may be incomplete as prescribers often omit the
quantity and frequency of each dose, using ‘as required’
and ‘as directed’ qualifiers. In these situations, researchers
need to revert to quantity and frequency of supply to
examine drug use. Finally, the design and validity of the
algorithm are based predominantly on a sample of 15 539
distinct dose instructions which focused on the most fre-
quently occurring instructions, and this is likely to explain
the variation by therapeutic area (Table 5). However, clini-
cal validation did include a second random sample from
each frequency stratum in Table 2. Nevertheless, research-
ers should remain vigilant in undertaking quality checks
throughout data transformation and analysis.
Future direction
The algorithm is now (April 2017) in operation and
researchers can request a free-text dose instruction trans-
lated output as part of their PIS data extract through
eDRIS, NHS National Services Scotland [www.isdscot
land.org/Products-and-Services/eDRIS/], the body that pro-
visions national datasets on behalf of NHS Scotland. A 12-
month review of the performance of the algorithm will be
undertaken, including feedback from users of the output,
and this will inform future algorithm versions. Preliminary
feedback from two early studies examining methadone17
and direct oral anticoagulant therapy16 has been positive.
Furthermore, our algorithm was applied to dose instruc-
tions as recorded by GPs, so it should be applicable to and
equally effective with data from other English language
Table 4. Types of rules in final algorithm
Type of rule Description Number
General High level definite clause grammar rules e.g. one or two as reqd every 4 to 6
hours for pain breakthrough dispense weekly quantity qualifier frequency
statement
23
Quantity Rules to identify and interpret the quantity to be taken in each dose e.g. one or
two minimum indicator of range maximum
34
Frequency Rules to identify and interpret instructions to take according to a number of
doses within a period e.g. 2–3 times daily minimum indicator of range maxi-
mum indicator of within period period unit
51
Rules to identify and interpret instructions to take according to intervals
between doses e.g. every 4 to 6 hours indicator of interval between minimum
indicator of range maximum interval unit
19
Qualifier Rules specific to identifying explicit or implicit instructions to take as required 10
Rules specific to identifying explicit or implicit instructions to take as directed 14
Other Rules to identify statements and other information that is not related to quantity,
frequency or qualifier e.g. for pain breakthrough, dispense weekly
89
Lexicons Rules used frequently throughout the program e.g. rules to identify numeric
values whether expressed as numbers or text
388
Keywords and their spelling variants e.g. daily, dialy, dailly 454
Specific keyword combinations that could not be processed by the general rule
sets e.g. 3 times daily 2.5 mls is equivalent to 2.5ml 3 times daily
400
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GP-based prescription datasets, such as the Clinical
Practice Research database (CPRD)18 or The Health
Improvement Network (THIN) database.19
Conclusion
We have presented the successful adoption of a text-
mining approach, through design and application of an
NLP algorithm, as a route to the provisioning of large
volumes of free-text dose instructions, generated through
capturing all electronic prescriptions (about 100 million
per annum) in primary care in Scotland. We have taken a
zero-assumption approach to the codification and produc-
tion of general rules to create the algorithm, ensuring that
users of the data have maximum flexibility to formulate,
test and apply their own assumptions according to the
medicines, population and research questions under inves-
tigation. Data science expertise will become ever more
important to assist the effective and safe management
of ‘big data’, to enable rapid creation of new clinical
knowledge for innovation in health services.
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